Current challenges in viral hepatitis, antimicrobial resistance and the influenza pandemic

Expert Rev Anti Infect Ther. 2009 Oct;7(8):945-9. doi: 10.1586/eri.09.79.

Abstract

The 3rd Ditan International Conference on Infectious Diseases was held from 29 July to 2 August 2009 at the Beijing International Conference Center, Beijing, China. Over 1000 participants from 27 countries attended the 4-day conference, titled 'World Dialogue on Infectious Diseases'. A broad range of topics were covered this year, including TB, methicillin-resistant Staphylococcus aureus, HIV, influenza and gastrointestinal infections. In addition, there was a particularly strong focus on two contrasting topics of viral hepatitis and antibiotic resistance, which is the focus of this meeting report.

MeSH terms

  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use
  • Congresses as Topic
  • Disease Outbreaks*
  • Drug Resistance, Bacterial*
  • Hepacivirus / drug effects
  • Hepatitis B virus / drug effects
  • Hepatitis B, Chronic* / drug therapy
  • Hepatitis B, Chronic* / epidemiology
  • Hepatitis B, Chronic* / virology
  • Hepatitis C, Chronic* / drug therapy
  • Hepatitis C, Chronic* / epidemiology
  • Hepatitis C, Chronic* / virology
  • Humans
  • Influenza A Virus, H1N1 Subtype* / drug effects
  • Influenza, Human* / epidemiology
  • Influenza, Human* / prevention & control
  • Influenza, Human* / virology

Substances

  • Antiviral Agents